|
|
Article: Lower costs, higher efficacy seen with drug-eluting stents.
- Article from:
- Internal Medicine News
- Article date:
- June 15, 2005
- Author:
CopyrightCOPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON -- With prices continuing to fall, drug-eluting coronary stents have become more cost effective than ever before.
Based on the price of drug-eluting stents, the average number of stents used per patient, and their efficacy at cutting the rate of restenosis, drug-eluting stents are now cost effective in any patient who would have a risk of restenosis of 10% or more if bare-metal stents were used for treatment, David J. Cohen, M.D., said at a meeting sponsored by the Cardiovascular Research Institute of the Washington Hospital Center.
In contrast, based on last year's averages, drug-eluting stents were cost effective whenever the restenosis rate ...